CAS 167465-36-3
:ZOSUQUIDAR TRIHYSROCHLORIDE
Description:
Zosuquidar trihydrochloride, identified by its CAS number 167465-36-3, is a chemical compound primarily studied for its potential role in cancer treatment, particularly in overcoming drug resistance in leukemia and other malignancies. It functions as a selective inhibitor of the P-glycoprotein (P-gp) efflux pump, which is often overexpressed in cancer cells and contributes to multidrug resistance by expelling therapeutic agents from the cells. The compound is typically characterized by its trihydrochloride salt form, which enhances its solubility in aqueous solutions, facilitating its use in biological studies. Zosuquidar has been evaluated in various preclinical and clinical settings, demonstrating the ability to sensitize resistant cancer cells to chemotherapy. Its pharmacological profile includes a focus on safety and efficacy, with ongoing research aimed at optimizing its use in combination therapies. As with many investigational drugs, the full spectrum of its properties, including pharmacokinetics and potential side effects, continues to be explored in clinical trials.
Formula:C32H32ClF2N3O2
InChI:InChI=1/C32H31F2N3O2.ClH/c33-32(34)29-22-7-1-3-9-24(22)31(25-10-4-2-8-23(25)30(29)32)37-17-15-36(16-18-37)19-21(38)20-39-28-13-5-12-27-26(28)11-6-14-35-27;/h1-14,21,29-31,38H,15-20H2;1H/t21?,29-,30+,31?;
Synonyms:- Ly335979, Rs 33295-198
- 1-{4-[(1aR,10bS)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c][7]annulen-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol hydrochloride
- Zosuquidar trihydrochloride
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
Zosuquidar Trihydrochloride
CAS:Formula:C32H34Cl3F2N3O2Purity:98%Color and Shape:SolidMolecular weight:636.9871Zosuquidar TriHCl
CAS:Formula:C32H31F2N3O2·3HClColor and Shape:Yellow SolidMolecular weight:527.62 3*36.46Zosuquidar trihydrochloride
CAS:Zosuquidar trihydrochloride (LY-335979 trihydrochloride) is a potent modulator of P-glycoprotein-mediated multi-drug resistance with Ki of 60 nM. Phase 3.Formula:C32H31F2N3O2·3HClPurity:99.49% - >99.99%Color and Shape:SolidMolecular weight:636.99Zosuquidar trihydrochloride
CAS:Inhibits P-gp transporters ; modulates P-gp-mediated multidrug resistance
Formula:C32H34Cl3F2N3O2Purity:Min. 95%Color and Shape:Yellow PowderMolecular weight:636.99 g/molrac Zosuquidar-d5 Trihydrochloride
CAS:Controlled ProductFormula:C32H29D5Cl3F2N3O2Color and Shape:NeatMolecular weight:532.635Zosuquidar Trihydrochloride
CAS:Controlled ProductApplications Multi-drug resistance (MDR) modulator; selective inhibitor of P-glycoprotein (P-gp). Antineoplastic adjunct (chemosensitizer).
References Green, L.J., et al.: Biochem. Pharmacol., 61, 1393 (2001), Shepard, R.L., et al.: Int. J. Cancer, 103, 121 (2003),Formula:C32H31F2N3O2·3ClHColor and Shape:NeatMolecular weight:636.99






